Reevaluation of the Retinal Dystrophy Due to Recessive Alleles of <i>RGR</i> With the Discovery of a Cis-Acting Mutation in <i>CDHR1</i>
Gavin Arno(Greenwood Genetic Center), Andrew R. Webster(Moorfields Eye Hospital), L. Ingeborgh van den Born(Rotterdam Eye Hospital), Christina Chakarova(University College London), Sarah Hull(Moorfields Eye Hospital NHS Foundation Trust), Eric A. Pierce(Broad Institute), Graham E. Holder(Moorfields Eye Hospital), Anthony G. Robson(Moorfields Eye Hospital NHS Foundation Trust), Arundhati Dev-Borman(Moorfields Eye Hospital NHS Foundation Trust), Michel Michaelides(Moorfields Eye Hospital), Frans P.M. Cremers(Radboud University Nijmegen), F. Lucy Raymond(University of Cambridge), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Anthony T. Moore(Cambridge University Hospitals NHS Foundation Trust), Keren Carss(AstraZeneca (United Kingdom))
Cited by 29
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.
|Journal of Medical Genetics|1997|1.2k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k